Maurice Buchbinder
Cardiovascular Disease · Encinitas, CANPI 1851369813
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $198,416 of the $233,720 with a category attached, or 84.9%. Catheter Precision, Inc. FKA Ra Medical Systems, Inc. accounts for 76.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $159,329 and has fallen 99.9% since, to $203 in 2025. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $2513.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Catheter Precision, Inc. FKA Ra Medical Systems, Inc.$180K
- Walk Vascular, LLC$25K
- Boston Scientific$24K
- Ablative Solutions, Inc.$2K
- Cordis US CORP.$500
- Ancora Heart, Inc.$438
- plus $1K from 23 others
Across 20 payments — averaging $3164.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$62K
- E.r. Squibb & Sons, L.L.C.$574
- AstraZeneca$415
What the payments were for
- Consulting fees$3,1251%
- Speaking & faculty fees$198,41685%
- Travel & lodging$4,5372%
- Food & beverage$2,6091%
- Other$25,03311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 17 | $179,518 |
| Walk Vascular, LLC | 1 | $25,033 |
| Boston Scientific | 20 | $24,319 |
| Ablative Solutions, Inc. | 1 | $2,415 |
| Cordis US CORP. | 1 | $500 |
| Ancora Heart, Inc. | 2 | $438 |
| Penumbra, Inc. | 1 | $235 |
| Medtronic | 5 | $218 |
| Abbott | 4 | $147 |
| E.r. Squibb & Sons, L.L.C. | 5 | $141 |
| Johnson & Johnson | 8 | $116 |
| Pfizer | 5 | $103 |
| Boehringer Ingelheim | 2 | $102 |
| Lundbeck LLC | 3 | $56 |
| Edwards Lifesciences | 1 | $53 |
| Amgen | 2 | $45 |
| AstraZeneca | 2 | $40 |
| Philips North America LLC | 1 | $32 |
| Terumo Medical Corporation | 1 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Amarin Pharma, Inc. | 1 | $23 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Angiodynamics, Inc. | 1 | $18 |
| Cvrx, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| GSK | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DABRA$144,609
- GENERAL - STRUCTURAL HEART$13,693
- Watchman$10,304
- MYNX CONTROL$500
- AccuCinch$438
- Indigo System$235
- Micra$131
How this compares
$233,720 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Encinitas
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.